Asset Value Investors (AVI), the manager of AVI Japan Opportunity Trust (AJOT) and AVI Global Trust (AGT), has launched a public campaign targeting portfolio holding Rohto Pharmaceutical (TSE: 4527). The campaign urges Rohto to concentrate on its profitable core businesses – namely skincare and eye care – and to step back from continued investment in … Continue reading AVI launches public campaign on Rohto Pharmaceutical